Cargando…
Tumor-Specificity Growth Factor Combined with Tumor Markers in Nuclear Medicine Imaging to Identify Prostate Cancer Osteonosus
OBJECTIVE: This study has explored the application value of malignant tumor SPE growth factor (TSGF) combined with tumor markers (TM) (TSGF + TM) in nuclear medicine imaging to identify prostate cancer osteonosus (PCO). METHODS: A retrospective analysis for 70 patients with prostate cancer and bone...
Autores principales: | Zhang, Xuemin, Chen, Zhengfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683177/ https://www.ncbi.nlm.nih.gov/pubmed/34925738 http://dx.doi.org/10.1155/2021/7380120 |
Ejemplares similares
-
Retracted: Tumor-Specificity Growth Factor Combined with Tumor Markers in Nuclear Medicine Imaging to Identify Prostate Cancer Osteonosus
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Effect of Combining Traditional Chinese Medicine with Hormonal Therapy on Quality of Life and Tumor Markers of Prostate Cancer Patients
por: Gai, Pengpeng, et al.
Publicado: (2021) -
Targeting Tumor Markers with Antisense Peptides: An Example of Human Prostate Specific Antigen
por: Štambuk, Nikola, et al.
Publicado: (2019) -
Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
por: Mishani, Eyal, et al.
Publicado: (2008) -
Limits of Tumor Detectability in Nuclear Medicine and PET
por: Erdi, Yusuf Emre
Publicado: (2012)